The risk of cardiac and clot-related complications following COVID-19 is substantially reduced in people who receive the COVID-19 vaccination compared with unvaccinated individuals, reports an observational study published ...
Mar 13, 2024
0
1
Using a defibrillator for a cardiac arrest victim improves 30-day survival even with ambulance response times as short as two minutes, according to research presented at ESC Congress 2023.
Aug 24, 2023
0
1
People with the inherited heart condition hypertrophic cardiomyopathy (HCM) who exercised vigorously did not have an increased incidence of serious cardiac events during three years of follow-up compared with people who exercised ...
Mar 7, 2023
0
1
A study published in JACC: Clinical Electrophysiology evaluates local impedance-based mapping as a tool to identify critical components of ventricular tachycardia after myocardial infarction. The study highlights the technique's ...
Feb 21, 2023
0
3
The good news is that fear can persuade us to avoid dangerous situations or help us flee from an angry bear.
Oct 24, 2022
0
8
Researchers from the University of Minnesota Medical School found that patients with certain features on magnetic resonance imaging (MRI) of the heart are at much higher risk for cardiac sarcoidosis-related adverse outcomes. ...
Oct 4, 2022
0
14
Basic life support training in schools and communities is essential to improve survival from cardiac arrest, according to European Society of Cardiology (ESC) Guidelines published online today in the European Heart Journal. ...
Aug 26, 2022
0
5
More than one in eight children (12%) receiving implanted cardiovascular defibrillators (ICDs) for heart rhythm problems exhibit signs of post-traumatic stress disorder (PTSD), according to a new report in Heart Rhythm. Importantly, ...
Aug 24, 2022
0
12
A first-in-human multicenter trial involving Mayo Clinic has used a new ablation technique for patients with ventricular tachycardia, an abnormally rapid heart rhythm that is a leading cause of sudden cardiac death worldwide.
Aug 17, 2022
0
20
Scientists from the National University of Singapore (NUS) Department of Pharmacy have developed an improved pharmaceutical drug for the treatment of the most common heart rhythm disturbance—atrial fibrillation (AF). The ...
Jul 18, 2022
0
312
